Existence Genetics

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article needs to be updated. Please help update this article to reflect recent events or newly available information. (August 2022) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "Existence Genetics" – news · newspapers · books · scholar · JSTOR (February 2017) (Learn how and when to remove this message) This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (September 2022) (Learn how and when to remove this message)

Existence Genetics was a genetic analysis and genetic reporting company that was founded in 2005 and declared bankruptcy on November 21, 2012.

The company was founded in 2005 by Brandon Colby MD,^[1] who also served as CEO, and was headquartered in Los Angeles, California.^[2]

It provided the healthcare industry and health & wellness organizations with access to information about their client's genes.^[2]

The company used the Nexus DNA Chip, which was developed in-house, manufactured by Illumina, and run in a CLIA-certified laboratory in the USA.^{[citation needed]} The Nexus DNA Chip was purported to test for thousands of clinically significant SNPs, DIPs, and CNVs, and be able to assess a person's risk of over 700 common and rare diseases.^[3]

In October 2010 Existence sued Wilson Sonsini for fraud and breach of contract concerning the law firm's representation of Existence in patent prosecution and over fund-raising advice.^[1]

In October 2011, Existence announced an upgrade to their genetic testing and analysis capabilities that they claimed allowed them to test for over 1,200 diseases, conditions, traits, and medication reactions.^[4]

It declared bankruptcy on November 21, 2012.^[5]